Travere Therapeutics, Inc. (TVTX)

CIK 1438533 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Travere Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Sep 11, 202640001506916-26-000004
Sep 10, 20261440001950047-26-009292
Sep 3, 202640001943192-26-000005
Aug 19, 202640001123343-26-000010
Aug 18, 20261440001950047-26-008327
Aug 17, 20261440001950047-26-008242
Aug 14, 2026SCHEDULE 13G/A0001172661-26-003621
Aug 12, 2026SCHEDULE 13G0000070858-26-000437
Aug 7, 2026SCHEDULE 13G0000093751-26-000546
Aug 6, 2026SCHEDULE 13G/A0000315066-26-002183
Aug 4, 20268-K0001438533-26-000062
Aug 4, 202610-Q0001438533-26-000063
Jul 9, 20268-K0001438533-26-000054
Jun 22, 202640001902368-26-000007
Jun 17, 2026S-80001438533-26-000052
Jun 16, 202640001376043-26-000010
Jun 16, 202640001680739-26-000014
Jun 16, 20268-K0001438533-26-000048
Jun 12, 20261440001950047-26-005979
Jun 12, 20261440001376043-26-000007
Jun 2, 20268-K0001193125-26-252474
May 21, 202640001123343-26-000004
May 21, 202640001619622-26-000002
May 21, 202640001506916-26-000003
May 21, 202640001344381-26-000004